Refyne Revenue and Competitors

Location

$105M

Total Funding

Finance

Industry

Estimated Revenue & Valuation

  • Refyne's estimated annual revenue is currently $23.3M per year.(i)
  • Refyne's estimated revenue per employee is $115,500
  • Refyne's total funding is $105M.

Employee Data

  • Refyne has 202 Employees.(i)
  • Refyne grew their employee count by 3% last year.

Refyne's People

NameTitleEmail/Phone
1
Head DesignReveal Email/Phone
2
Associate Director - ProductReveal Email/Phone
3
Chief Growth OfficerReveal Email/Phone
4
Operations ManagerReveal Email/Phone
5
Associate Manager - People & CultureReveal Email/Phone
6
Product ManagerReveal Email/Phone
7
Sr. Manager - Product Delivery & Customer ExperienceReveal Email/Phone
8
Associate Manager OperationsReveal Email/Phone
9
People ManagerReveal Email/Phone
10
Senior Manager SalesReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$144.1M98011%N/AN/A
#2
$150.1M102112%N/AN/A
#3
$321M218426%N/AN/A
#4
$44.6M34028%N/AN/A
#5
$201.8M1373-2%N/AN/A
#6
$19.3M167-8%N/AN/A
#7
$288.4M196211%N/AN/A
#8
$18.2M1585%N/AN/A
#9
$113.9M77510%N/AN/A
#10
$49M37312%N/AN/A
Add Company

What Is Refyne?

Refyne partners with organisations to extend real-time, on-demand earned wage access to their employees. We believe that access to earned salary lies at the heart of a stress-free and productive workforce. Our one-stop platform enables you to build financial resilience in your employee base. With our simple plug and play technology, employees can see and withdraw their earned salary without succumbing to exploitative payday loans or other high-interest credit schemes. Become part of the growing network of employers who truly reflect an employee-first approach.

keywords:N/A

$105M

Total Funding

202

Number of Employees

$23.3M

Revenue (est)

3%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Refyne News

2022-04-20 - Study Design and Outcomes of the Phase II REFINE Trial

A review of the study design and key efficacy and safety outcomes of the REFINE trial studying ruxolitinib plus navitoclax treatment in...

2022-04-20 - Potential Implications of the REFINE Trial on the Myelofibrosis ...

Naveen Pemmaraju, MD, talks about the potential implications of the phase II REFINE trial on the myelofibrosis treatment paradigm.

2022-04-06 - How Bengaluru startup Refyne is enabling earned wage access to employees

How Bengaluru startup Refyne is enabling earned wage access to employees ... Founded in 2020 by Chitresh Sharma and Apoorv Kumar, the startup...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$14.1M2027%$33M
#2
$39.4M20320%N/A
#3
$16.2M2030%N/A
#4
$16.2M2037%N/A
#5
$16.2M2037%N/A